Skip to main content
SpringerLink
Log in
SpringerLink
Log in

Thrombophilic Risk Parameters in Juvenile »Idiopathic« Stroke Patients

  • Conference paper
31st Hemophilia Symposium Hamburg 2000

  • 107 Accesses

Abstract

Within the last decade, various genetic defects of proteins regulating blood coagulation, particularly those affecting the physiological anticoagulant systems, have been well established as risk factors of cerebrovascular disease in adults [8;22;23]. Besides the high thrombotic risk reported in patients with homozygous FV:R506Q mutation, homozygous protein C deficiency, homozygous protein S deficiency and homozygous homocysteinuria due to cystathionine-ß-synthase (CBS) deficiency, a high risk of early thrombotic onset is observed in patients with heterozygous anti-thrombin deficiency, heterozygous protein C deficiency of the so-called dominant type, and heterozygous protein S deficiency [18;29;40].

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Bentolila S, Ripoll L, Drouet L, Mazoyer E, Woimant F. Thoombophilia due to 20210 G-A prothrombin polymorphism and cerebral ischemia in the young. Stroke 1997; 28: 1846

    PubMed  CAS  Google Scholar 

  2. Bertina RM, Linden van der IK, Engesser L, Muller HP, Brommer EJP. Hereditary heparin Cofactor II deficiency and the risk of development of thrombosis. Thromb Haemost 1987; 57: 196–200

    PubMed  CAS  Google Scholar 

  3. Bertina RM, Koelemann BP, Koster T. Mutation in blood coagulation factor V associated with resistance to activated protein C. Nature 1994; 369: 64–7

    Article  PubMed  CAS  Google Scholar 

  4. Bostom AG, Rosenberg ICH, Silberhatz H, Jacques PF, Selhub J, D’ Agostino RB, Wilson PW, Wolf PA. Nonfasting plasma total homocysteine levels and stroke incidence in elderly persons: the Framingham Study. Ann Intern Med 1999; 131: 352–5

    PubMed  CAS  Google Scholar 

  5. Corral A, Gonzalezconejero R, Lozano ML, Rivera J, Heras I, Vicente V. The venous thrombosis risk factor 20210 a allele of the prothrombin gene is not a major risk factor for arterial thrombotic disease. Br J Haematol 1997; 99: 304

    Article  PubMed  CAS  Google Scholar 

  6. Cushman M, Bhushan F, Bovill E, Tracy R. Plasma resistance to activated protein C in venous and arterial thrombosis. Thromb Haemost 1994; 72: 647

    PubMed  CAS  Google Scholar 

  7. Dahlbäck B, Hildebrand B. Inherited resistance to activated protein C is corrected by anticoagulant cofactor activity found to be a property of factor V. Proc Nat Acad Sc 1994; 91: 1396–400

    Article  Google Scholar 

  8. De Stefano V, Finazzi G, Mannucci PM. Inherited thrombophilia: Pathogenesis, clinical syndromes and management. Blood 1996; 87: 3531–44

    PubMed  Google Scholar 

  9. De Stefano V, Chiusolo P, Paciaroni K, Casorelli I, Rossi E, Molinari M, Servidei S, Tonali PA, Leone G. Prothrombin G20210 A mutant genotype is a risk factor for cerebrovascular ischemic disease in young patients. Blood 1998; 91: 3562–5

    PubMed  Google Scholar 

  10. Ferraresi P, Marchetti G, Legnani C, Cavallari E, Castoldi E, Mascoli F, Ardissino D, Palareti G, Bernardi F. The heterozygous 20210 G/A prothrombin genotype is associated with early venous thrombosis in inherited thrombophilia and is not increased in frequency in artery disease. Arterioscler Thromb Vasc Biol 1997; 17: 2418

    Google Scholar 

  11. Folsom AR, Rosamond WD, Shahar E, Cooper LS, Aleksic N, Nieto FJ, Rasmussen ML, Wu KK. Prospective study of markers of hemostatic function with risk of ischemic stroke. The Atherosclerosis Risk in Communities (ARIC) Study Investigators. Circulation 1999; 100: 736–42

    PubMed  CAS  Google Scholar 

  12. Gaustades M, Rudiger N, Moller J, Rasmussen K, Bjerregaard Larsen T, Ingerslev J. Thrombophilic predisposition in stroke and venous thromboembolism in Danish patients. Blood Coagul Fibrinolysis 1999; 10: 251–9

    Article  Google Scholar 

  13. Halbmayer WM, Mannhalter C, Feichtinger C, Rubi K, Fischer M. The prevalence of factor XII deficiency in 103 orally anticoagulated outpatients suffering from venous and/or arterial thromboembolism. Thromb Haemost 1992; 68: 285–90

    PubMed  CAS  Google Scholar 

  14. Halbmayer WM, Haushofer A, Schön R, Fischer M. The prevalence of poor anticoagulant response to activated protein C (APC resistance) among patients suffering from stroke or venous thrombosis and among healthy subjects. Blood coag Fibrinol 1994; 5: 51–7

    Article  CAS  Google Scholar 

  15. Haverkate F, Samama M. Familial dysfibrinogenemia and thrombophilia. Report on a study of the SSC subcommittee on fibrinogen. Thromb Haemost 1995; 73: 151–61

    PubMed  CAS  Google Scholar 

  16. Iniesta JA, Corral J, Fernandez-Pardo J, Gonzalez-Conejero R, Vicente V. Factor-V (Arg506Gln) mutation in ischemic cerebrovascular disease. Haemostasis 1997; 27: 105–11

    PubMed  CAS  Google Scholar 

  17. Kapur RK, Mills LA, Spitzer SG, Hultin MB. A prothrombin gene mutation is significantly associated with venous thrombosis. Arter Thromb Vasc Biol 1997; 17: 2875–9

    Article  CAS  Google Scholar 

  18. Koster T, Rosendaal FR, de Ronde H, Briet E, Vandenbroucke JP, Bertina RM. Venous thrombosis due to poor anticoagulant response to activated protein C: Leiden. Thrombophilia Study. Lancet 1993; 342: 1503–6

    Article  PubMed  CAS  Google Scholar 

  19. Koster T, Rosendaal FR, Briet E, Vandenbroucke JP. John Hagemann’s factor and deep vein thrombosis: Leiden Thrombophilia Study. Br. J Haematol 1994; 87: 422–4

    Article  PubMed  CAS  Google Scholar 

  20. Lalouschek W, Aull S, Serles W, Schnider P, Mannhalter C, Lang T, Deecke L, Zeiler K. Genetic and nongenetic factors influencing plasma homocysteine levels in patients with ischemic cerebrovascular disease and in healthy control subjects. J Lab Clin Med 1999; 133: 575–82

    Article  PubMed  CAS  Google Scholar 

  21. Lalouschek W, Auell S, Series W, Mannhalter C, Zeiler K. The prothrombin G20210 A mutation and factor V Leiden mutation in patients with cerebrovascular disease. Blood 1998; 92: 704–05

    PubMed  CAS  Google Scholar 

  22. Lane DA, Mannucci PM, Bauer KA, Bertina RM, Bochkov NP, Boulyjenkov V, Chandy M, Dahlbäck B, Ginter EK, Miletich JP, Rosendaal FR, Seligsohn U. Inherited thrombophilia: Part 1. Thromb Haemost 1996; 76: 651–2

    PubMed  CAS  Google Scholar 

  23. Lane DA, Mannucci PM, Bauer KA, Bertina RM, Bochkov NP, Boulyjenkov V, Chandy M, Dahlbäck B, Ginter EK, Miletich JP, Rosendaal FR, Seligsohn U. Inherited thrombophilia: Part 2. Thromb Haemost 1996; 76: 823–34

    Google Scholar 

  24. Longstreth WT Jr., Rosendaal FR, Siscovick DS, Vos HL, Schwartz SM, Psaty BM, Raghunathan TE, Koepsell TD, Reitsma PH. Risk of stroke in young women and two pro-thrombotic mutations: factor V Leiden and prothrombin gene variant (G20210 A). Stroke 1998; 29: 577–80

    Article  PubMed  Google Scholar 

  25. Margaglione M, D’ Andrea G, Giuliani N, Brancaccio V, De Lucia D, Grandone E, De Stefano V, Tonali PA, Di Minno G. Inherited prothrombotic conditions and premature ischemic stroke: sex difference in the association with factor V Leiden. Arterioscler Thromb Vasc Biol 1999; 19: 1751–6

    Article  PubMed  CAS  Google Scholar 

  26. Martinelli I, Franchi F, Akwan S, Bettini P, Merati G, Mannucci PM. The transition G to A at position 20210 in the 3’ untranslated region of the prothrombin gene is not associated with cerebral ischemia. Blood 1997; 90: 3806

    PubMed  CAS  Google Scholar 

  27. Mohanty S, Saxena R, Behari M. Risk factors for thrombosis in nonembolic cerebrovascular disease. Am J Hematol 1999; 60: 239–41

    Article  PubMed  CAS  Google Scholar 

  28. Mohanty S, Saxena R, Behari M. Activated protein C (APC) resistance in young stroke patients. Thromb Haemost 1999; 81: 465–6

    PubMed  CAS  Google Scholar 

  29. Mudd SH, Skovby F, Levy HL, Pettigrew KD, Wilcken B, Pyeritz RE, Audria G, Boers GHJ, Homberg IL, Cerone R, Fowler B, Gröbe H, Schmidt H, Schweitzer L. The natural history of homocysteinuria due to cystathionine -ß-synthase deficiency. Am J Hum Genet 1985; 37: 1–31

    PubMed  CAS  Google Scholar 

  30. Munts AG, van Genderen PJ, Dippel DW, van Kooten F, Koudstaal PJ. Coagulation disorders in young adults with acute cerebral ischemia. J Neurol 1998; 245: 21–5

    Article  PubMed  CAS  Google Scholar 

  31. Nabari DG, Junker R, Wolff E, Ludemann P, Doherty C, Evers S, Droste DW, Kessler C, Assmann G, Ringelstein EB. Prevalence of factor V Leiden mutation in young adults with cerebral ischemia: a case-control study on 225 patients. J Neurol 1998; 245: 653–8

    Article  Google Scholar 

  32. Nowak-Göttl U, Debus O, Findeisen M, Kassenböhmer R, Koch HG, Pollmann H, Postler C, Weber P, Vielhaber H. Lipoprotein(a): its role in childhood thromboembolism. Pediatrics (electronic pages) 1997; 99/6e11

    Article  Google Scholar 

  33. Poort SR, Rosendaal FR, Reitsma PH, Bertina RM. A common genetic variation in the 3’untranslated region of the prothrombin gene is associated with elevated plasma pro-thrombin levels and an increase in venous thrombosis. Blood 1996; 88: 3698–703

    PubMed  CAS  Google Scholar 

  34. Press RD, Liu XY, Beamer N, Coull BM. Ischemic stroke in the elderly. Role of the common factor V mutation causing resistance to activated protein C. Stroke 1996; 27: 44–8

    Article  PubMed  CAS  Google Scholar 

  35. Ridker PM, Hennekens CH, Lindpaintner K, Stampfer MJ, Eisenberg PR, Miletich JP. Mutation in the gene coding for coagulation factor V and the risk for myocardial infarction, stroke, and venous thrombosis in apparently healthy men. NEJM 1995; 332: 912–7

    Article  PubMed  CAS  Google Scholar 

  36. Ridker PM, Hennekens CH, Miletich JR G20210 A mutation in prothrombin gene and risk of myocardial infarction, stroke, and venous thrombosis in a large cohort of US men. Circulation 1999; 99: 999–1004

    PubMed  CAS  Google Scholar 

  37. Rosendaal FR, Koster T, Vandenbroucke JP, Reitsma PH. High risk of thrombosis in patients homozygous for factor V Leiden (Activated protein C resistance). Blood 1995; 85: 1504–8

    PubMed  CAS  Google Scholar 

  38. Sartori MT, Patrassi GM, Theodoridis P, Perin A, Pietrogrande F, Girolami A. Heterozygous type I plasminogen deficiency is associated with an increased risk for thrombosis: a statistical analysis in 20 kindreds. Blood Coag Fibrinol 1994; 5: 889–93

    Article  CAS  Google Scholar 

  39. Selhub J, D’Angelo A. Hyperhomocysteinemia and thrombosis: acquired conditions. Thromb Haemost 1997; 78: 527–31

    PubMed  CAS  Google Scholar 

  40. SeligsohnU, Zivelin A. Thrombophilia as a multigenetic disorder. Thromb Haemost 1997; 78 (1): 297–301

    PubMed  CAS  Google Scholar 

  41. Tosetto A, Ruggeri M, Castaman G, Rodeghiero E Inherited abnormalities of blood coagulation in juvenile stroke. A case-control study. Blood Coagul Fibrinolysis 1997; 8: 397–402

    Article  PubMed  CAS  Google Scholar 

  42. WHO Collaborative study of cardiovascular disease and steroid hormone contraception. Lancet 1996; 348: 498–505

    Article  Google Scholar 

Download references

Authors
  1. M. Krause
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. S. Ehrenforth
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. E. Aygören-Pürsün
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. G. Ludwig
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. I. Scharrer
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Hemophilia Center, Dept. of Internal Medicine, University Hospital, Theodor-Stern-Kai 7, D-60590, Frankfurt am Main, Germany

    Inge Scharrer

  2. Dept. of Hemostasiology, University Hospital, Ziemssenstr. 1a, D-80336, München, Germany

    Wolfgang Schramm

Rights and permissions

Reprints and permissions

Copyright information

© 2002 Springer-Verlag Berlin Heidelberg

About this paper

Cite this paper

Krause, M., Ehrenforth, S., Aygören-Pürsün, E., Ludwig, G., Scharrer, I. (2002). Thrombophilic Risk Parameters in Juvenile »Idiopathic« Stroke Patients. In: Scharrer, I., Schramm, W. (eds) 31st Hemophilia Symposium Hamburg 2000. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-59383-3_36

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-59383-3_36

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-540-42131-3

  • Online ISBN: 978-3-642-59383-3

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation